scholarly journals Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses

2014 ◽  
Vol 2014 ◽  
pp. 1-6
Author(s):  
Azam Bakhtiarian ◽  
Nasrin Takzare ◽  
Mehdi Sheykhi ◽  
Narges Sistany ◽  
Farahnaz Jazaeri ◽  
...  
Keyword(s):  
Cleft Palate ◽  
Normal Saline ◽  
Concomitant Administration ◽  
Control Group ◽  
Teratogenic Effects ◽  
Pregnant Rats ◽  
Palate Development ◽  
Rat Fetuses ◽  
Significant Rate ◽  
High Doses

Objective. Depression during pregnancy is a relatively common problem. Since little is known about the teratogenic effects of concomitant administration of fluoxetine and olanzapine during the organogenesis period, the aim of the present study was to evaluate the teratogenic effects of coadministration of fluoxetine and olanzapine on rat fetuses.Method. Forty-two pregnant rats were divided into seven groups, randomly. The first group received 0.5 mL of normal saline as the control. The second and third groups received fluoxetine at doses of 9 mg/kg and 18 mg/kg, respectively. Olanzapine was injected at 3 mg/kg and 6 mg/kg to the fourth and fifth groups, respectively. The sixth group received 9 mg/kg fluoxetine and 3 mg/kg olanzapine. Finally, the seventh group was administrated with fluoxetine and olanzapine at 18 mg/kg and 6 mg/kg, respectively. Drugs were injected intraperitoneally between day eight and day 15 of the pregnancy. On the 17th day of pregnancy, the fetuses were removed and micro-/macroscopically studied.Results. Fetuses of rats receiving high doses of these drugs showed a significant rate of cleft palate development, premature eyelid opening and torsion anomalies, compared to the control group (P≤0.01). It is concluded that these drugs can lead to teratogenicity, so their concomitant use during pregnancy should be avoided, or if necessary their doses must be decreased.

scholarly journals The Role of Clomipramine in Potentiating the Teratogenic Effects of Caffeine in Pregnant Rats: A Histopathological Study

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Vahid Nikoui ◽  
Sattar Ostadhadi ◽  
Nasrin Takzare ◽  
Seyyed Mohammad-Ali Nabavi ◽  
Mario Giorgi ◽  
...  
Keyword(s):  
Normal Saline ◽  
Histopathological Study ◽  
Simultaneous Administration ◽  
Teratogenic Effects ◽  
Pregnant Rats ◽  
Palate Development ◽  
Rat Fetuses ◽  
Group Control ◽  
High Doses

Since little is known about the teratogenic effects of clomipramine used concurrently with caffeine during the organogenesis period, the aim of this study was to test the teratogenic effects of a coadministration of caffeine and clomipramine on rat fetuses. We divided 42 pregnant rats into seven groups, randomly. The first group (control) received 0.5 mL of normal saline. Clomipramine was injected at 40 mg/kg and 80 mg/kg to the second and third groups, respectively. The fourth and fifth groups received caffeine in doses of 60 mg/kg and 120 mg/kg, respectively. The sixth group received a combination of 40 mg/kg clomipramine and 60 mg/kg caffeine, and the seventh group was given clomipramine and caffeine at 80 mg/kg and 120 mg/kg, respectively. The fetuses were removed on the 17th day of pregnancy and studied in terms of microscopic and macroscopic morphological features. Fetuses of rats receiving high doses of caffeine or combinations of caffeine and clomipramine showed a significant rate of cleft palate development, open eyelids, mortality, torsion anomalies, shrinkage of skin, and subcutaneous haemorrhage (P≤0.001). This study concludes that caffeine in high doses or the simultaneous administration of caffeine and clomipramine leads to teratogenicity.

Is it Possible to Prevent Cleft Palate by Prenatal Administration of Folic Acid? An Experimental Study

2001 ◽  
Vol 38 (4) ◽  
pp. 393-398 ◽  
Author(s):  
Volker Bienengräber ◽  
Fathi A. Malek ◽  
Klaus-Uwe Möritz ◽  
Jochen Fanghänel ◽  
Karsten K. H. Gundlach ◽  
...  
Keyword(s):  
Experimental Study ◽  
Folic Acid ◽  
Cleft Palate ◽  
Cleft Lip ◽  
Caesarian Section ◽  
Control Group ◽  
Fetal Head ◽  
Pregnant Rats ◽  
Experimentally Induced

Objective: In this study, folic acid was tested for its antiteratogenic effects on experimentally induced cleft palate in animals. Design: Eleven pregnant Lew 1 A dams (75 fetuses) received 200 mg/kg procarbazine via gastric tubing on postconception (p.c.) day 14 to induce a cleft palate (CP); seven of the pregnant dams (45 fetuses) were additionally given 4 mg/kg folic acid subcutaneously from the 14th to the 17th day p.c. As a control group, three more pregnant dams (24 fetuses) were not treated with the drugs mentioned above. All fetuses were delivered by Caesarian section on day 20 p.c. Outcomes measured: All fetuses were weighed and examined macroscopically with a stereomicroscope. Each fetal head was cut into 35 frontal sections and scrutinized histologically. Results: None of the control fetuses (n = 24) exhibited a cleft. Without folate administration, 90% of the fetuses (27 of 30) that received procarbazine exhibited a CP. After additional prenatal folate administration, this rate remained virtually unchanged (91%; 41 of 45). However, the proportion of complete (total) CP (4%) was significantly (p < .0001) lower than in the group without folate (53%). Cleft-associated microgenia and microglossia were also significantly less frequent when folate was administered prenatally: microgenia was reduced by 22% (p = .029) and microglossia by 24% (p = .032). Conclusions: On the basis of these results, folate has a partial ameliorating effect on the teratogenicity of procarbazine given to pregnant rats. Additional studies are necessary on the effect of folate in different species, also taking cleft lip and CP into consideration.

scholarly journals Evaluation of anti-nociceptive effect of venlafaxine in experimental animal model of mice

2019 ◽  
Vol 8 (12) ◽  
pp. 2598
Author(s):  
Sandeep Kumar Bandapati ◽  
Karuna Sree Podila ◽  
Yadala Venkata Rao
Keyword(s):  
Chronic Pain ◽  
Animal Model ◽  
Normal Saline ◽  
Subjective Experience ◽  
Concomitant Administration ◽  
Immersion Test ◽  
Poor Quality ◽  
Combination Group ◽  
Control Group ◽  
Tail Immersion

Background: Pain is an unpleasant sensation with varying subjective experience. Its management is always challenging for physicians particularly in case of chronic pain. Chronic pain and depression usually co-exist due to poor quality of life and increase in health care costs posing an individual to suffer from depression. Anti-depressants for pain management are being used successfully using since years. In this study venlafaxine, a newer anti-depressant drug was evaluated for anti-nociceptive activity, tail immersion test an analgesic animal model of albino mice.Methods: Randomly selected albino mice of either sex with reaction time of <6 seconds were included in the study and divided into 7 groups with 6 mice in each group. Grouping was done based on the drug received i.e., venlafaxine 15, 30 and 60 mg/kg, tramadol 10 and 20 mg/kg, control group (normal saline) and combination group venlafaxine 15 mg/kg+tramadol 10 mg/kg. Drugs were administered by intra-peritoneal route.Results: Venlafaxine (30 and 60 mg/kg), tramadol (20 mg/kg) and combination group venlafaxine (15 mg/kg+tramadol 10 mg/kg) has shown significant (p<0.001) increase in tail withdrawal latency compared to control group (normal saline) by tail immersion test. Venlafaxine potentiated anti-nociceptive activity of tramadol on concomitant administration with tramadol. Venlafaxine at 60 mg/kg has comparable anti-nociceptive effect to tramadol at 20 mg/kg.Conclusions: Venlafaxine at doses of 30 and 60 mg/kg is having anti-nociceptive effect, but less potent than tramadol.

scholarly journals The Teratogenic Mechanism of Echinochrome as a Hypoglycemic Agent on Wistar Rats

2019 ◽  
Vol 9 (1) ◽  
pp. 79-83
Author(s):  
Ayman S. Mohamed ◽  
Eman Y. Salah EL Din ◽  
Neveen A. Farag ◽  
Abdel Rahman A. Tawfik
Keyword(s):  
Wistar Rats ◽  
Low Dose ◽  
Body Weight Gain ◽  
Control Group ◽  
High Dose ◽  
Teratogenic Effects ◽  
Pregnant Rats ◽  
Hypoglycemic Agent ◽  
Group Control ◽  
Group Control Group

Background: Echinochrome (Ech) is the active ingredient in the Histochrome drug, which possesses strong antioxidant, hypolipidemic and hypoglycemic activity. Objective: The present work aimed to characterize the malformations induced by moderate and high dose of Ech during pregnancy. Methods: In this study, eighteen (18) female pregnant rats were assigned into 3 groups (6 rats/ group); control group, low dose Ech (0.1 mg/kg) and high dose Ech (1 mg/kg). Results: The high dose of Ech caused a significant decrease in the number of embryos, uteri weight, body weight gain, placenta weight, and embryo weight and length. Also, the high dose led to a significant increase in serum AST, ALT, ALP, urea and uric acid of mothers. Conclusion: Our findings revealed the first teratogenic effects of high dose Ech. The teratogenic mechanism of Ech works through induction of the hypoglycemic condition in pregnant rats.

scholarly journals Teratogenic Potential of Solenstemma Argel Extract in Wistar Albino Rats

2021 ◽  
Author(s):  
Nazik M.E. Mustafa ◽  
Shahenaz Satti ◽  
Nafisa A. Osman ◽  
Ahmed A.Gameel ◽  
Tarig M. El-hadiyah
Keyword(s):  
Fetal Development ◽  
Treated Group ◽  
Control Group ◽  
Albino Rats ◽  
P Value ◽  
Teratogenic Effects ◽  
Pregnant Rats ◽  
Liver Histopathology ◽  
Teratogenic Potential ◽  
Wistar Albino Rats

Abstract The majority of people in Africa receive their basic health care through herbal treatments. Herbal medicine may negatively impact fetal development irreparably. This study examined the teratogenic potential of Solenstemma argel extract in pregnant rats. Pregnant rats were treated with Solenstemma argel from 7th to 16th day of gestation. The dosage used was 250 mg/kg, intraperitoneal.Solenstemma argel extract treated group showed fetal abnormalities appeared as body hemorrhage, limbs abnormalities and resorption of fetuses. These appears in 25% of the fetuses (P-value = 0.01) which is significantly differed from control group. Furthermore, histopathological findings of liver sections from fetuses of Solenstemma argel - treated mothers showed loose liver texture and hepatocytes hemorrhage.In this study, we conclude that the use Solenstemma argel extract during the organogenesis period in pregnant rats has the potential to cause teratogenic effects, as well as abnormalities in liver histopathology.

scholarly journals Teratogenic effects of imidacloprid in rats: mechanistic role of oxidative stress

2019 ◽  
Vol 7 (2) ◽  
pp. 35
Author(s):  
Nermeen Borai El-Borai ◽  
Seham Said Hadad ◽  
Hanem Kamal Khalifa
Keyword(s):  
Oxidative Stress ◽  
High Dose ◽  
Dependent Manner ◽  
Teratogenic Effects ◽  
Pregnant Rats ◽  
Skeletal Malformations ◽  
Fetal Malformations ◽  
High Doses ◽  
Dose Dependent

Extensive use of imidacloprid (IMI) insecticide in the agro-vet practices leads to continuous animal and human exposure. Exposure of pregnant dams to such insecticides results in fetal malformations. In the light of this, the present study was designed to investigate the teratogenic effects of two different doses of IMI and the possible mechanistic role of oxidative stress. Fifteen pregnant females were randomly divided into three equal groups and orally treated daily during organogenesis period (6-15th GD), control (distilled water), LD-IMI (45 mg/kg) and HD-IMI (90 mg/kg). All pregnant dams were exposed to caesarean section on GD 20. Exposure to IMI induced significant increase in the percentage of resorptions at high-dose with significant reduction of fetal and placental weights in a dose-dependent manner. External fetal morphological abnormalities were recorded only at high-dose while several visceral abnormalities were observed in fetuses at low- and high-doses. Significant increases in the percentages of fetal skeletal malformations were recorded only in the high-dose group. Significant changes in MDA, GSH levels and CAT activity with insignificant change in the level of H2O2 were recorded only in placentae of LD-IMI group. However, all these parameters recorded significant changes in serum of dams, placentae and liver of fetuses at high-dose. In conclusion, exposure of pregnant rats to IMI, particularly at higher-dose, during the period of organogenesis induced fetal teratogenic effects that may be related to its maternal and fetal oxidative damaging impacts.   

scholarly journals A model for the study of skeletal anomalies in rat fetuses

2004 ◽  
Vol 47 (1) ◽  
pp. 33-39 ◽  
Author(s):  
Cristiane Effting ◽  
Daniel Jesus de Paula ◽  
Guilhermino Pereira Nunes Junior
Keyword(s):  
Treated Group ◽  
Placental Weight ◽  
Control Group ◽  
Pregnant Rats ◽  
Rat Fetuses ◽  
Skeletal Anomalies

The aim of this study was to validate a model of skeletal anomalies in rat fetuses by the administration of ketoconazole (80 mg/kg) to pregnant rats during organogenesis. Bones of the head, trunk and anterior and posterior limbs were examined for detection of anomalies. Statistical differences regarding the number of fetuses and postimplantation resorptions, and fetal and placental weight were significant. The frequency of skeletal anomalies in the head, trunk, and anterior and posterior limbs in the ketoconazole-treated group were also significant when compared to the control group. It could be concluded that the model suggested was valid for study of skeletal anomalies and abnormal bones development in rat fetuse, in spite of the loss of fetuses due to resorptions.

scholarly journals Teratogenic Potential of Solenstemma argel Extract in Wistar Albino Rats

2022 ◽  
Author(s):  
Nazik M.E. Mustafa ◽  
Shahenaz Satti ◽  
Nafisa A. Osman ◽  
Ahmed A.Gameel ◽  
Tarig M. El-hadiyah
Keyword(s):  
Fetal Development ◽  
Treated Group ◽  
Control Group ◽  
Albino Rats ◽  
P Value ◽  
Teratogenic Effects ◽  
Pregnant Rats ◽  
Liver Histopathology ◽  
Teratogenic Potential ◽  
Wistar Albino Rats

Abstract The majority of people in Africa receive their basic health care through herbal treatments. Herbal medicine may negatively impact fetal development irreparably. This study examined the teratogenic potential of Solenstemma argel extract in pregnant rats. Pregnant rats were treated with Solenstemma argel from 7th to 16th day of gestation. The dosage used was 250 mg/kg, intraperitoneal.Solenstemma argel extract treated group showed fetal abnormalities appeared as body hemorrhage, limbs abnormalities and resorption of fetuses. These appears in 25% of the fetuses (P-value = 0.01) which is significantly differed from control group. Furthermore, histopathological findings of liver sections from fetuses of Solenstemma argel - treated mothers showed loose liver texture and hepatocytes hemorrhage.In this study, we conclude that the use Solenstemma argel extract during the organogenesis period in pregnant rats has the potential to cause teratogenic effects, as well as abnormalities in liver histopathology.

scholarly journals Ketoconazole- and fluconazole-induced embryotoxicity and skeletal anomalies in wistar rats: a comparative study

2008 ◽  
Vol 51 (6) ◽  
pp. 1153-1161 ◽  
Author(s):  
Vanessa Cristiane de Santana Amaral ◽  
Guilhermino Pereira Nunes Junior
Keyword(s):  
Comparative Study ◽  
Wistar Rats ◽  
Treated Group ◽  
Control Group ◽  
Pregnant Rats ◽  
Alizarin Red ◽  
Azole Antifungals ◽  
Skeletal Anomalies ◽  
High Doses ◽  
Embryotoxic Effects

Ketoconazole and fluconazole are two broad-spectrum azole antifungals used for the treatment of superficial and systemic mycoses. Embryotoxicity and teratogenicity have been reported in some studies when those drugs are administered at high doses to pregnant rats. The aim of this study was to present a comparative study of embryotoxic effects as well as the skeletal anomalies in fetuses of Wistar rats which received ketoconazole and fluconazole at teratogenic doses on gestational days (GD) 6 through 15 (organogenesis period). On gestational day (GD) 21, the dams were euthanized and examined for standard parameters of reproductive outcome. Fetuses were stained with alizarin red and the bones of the head, trunk, forelimb and hindlimb were examined for detection of skeletal anomalies. The frequency of skeletal anomalies in the ketoconazole-treated group was significant when compared to the fluconazole and the control group.

scholarly journals A COMPARATIVE STUDY OF INTRATHECAL BUPIVACAINEHEAVY (0.5%) WITH BUPIVACAINE HEAVY (0.5%) PLUS DEXMEDETOMIDINE FOR LOWER ABDOMINAL SURGERIES

2021 ◽  
Vol 5 (2) ◽  
Author(s):  
Kumar Shailesh ◽  
Jitendra Prasad Singh ◽  
Arjun Prasad ◽  
Veena Horo
Keyword(s):  
Side Effects ◽  
Normal Saline ◽  
Motor Block ◽  
Onset Time ◽  
Local Anaesthetics ◽  
Control Group ◽  
Hyperbaric Bupivacaine ◽  
Rescue Analgesia ◽  
High Doses ◽  
Group D

Introduction: Several adjuncts like adrenaline, opioids and alpha-2 adrenergic agonists are being used with local anaesthetics intrathecally for prolongation of intra-operative and post-operative analgesia and to reduce the side-effects of high doses of local anaesthetics. Aim: The present study was done to evaluate the onset and duration of sensory and motor block, hemodynamic effects, post-operative analgesia and adverse effects of Dexmedetomidine given intrathecally with hyperbaric 0.5% Bupivacaine. Materials and methods: Sixty inpatients of ASA class I and II scheduled for various lower abdominal surgeries under Sub-Arachnoid Block were randomly divided into two groups of 30 each namely C (Control), D(Dexmedetomidine) . All received 12.5mg hyperbaric bupivacaine plus 0.5 ml Normal Saline in Group C (Control),10µg Dexmedetomidine (diluted in preservative free Normal saline of 0.5ml) in Group D(Dexmedetomidine) . The onset time to reach peak sensory and motor level, the regression time for sensory and motor block, hemodynamic changes and side-effects were noted. Results: The duration of sensory and motor block, rescue analgesia was significantly prolonged in Dexmedetomidine group when compared to that of Control group. Conclusion: Dexmedetomidine 10 µg seems to be a better neuraxial adjuvant to hyperbaric Bupivacaine. Keywords: Bupivacaine; Dexmedetomidine; intrathecal.

Sign in / Sign up

Export Citation Format

Share Document